JP2001031587A5 - - Google Patents

Download PDF

Info

Publication number
JP2001031587A5
JP2001031587A5 JP2000159149A JP2000159149A JP2001031587A5 JP 2001031587 A5 JP2001031587 A5 JP 2001031587A5 JP 2000159149 A JP2000159149 A JP 2000159149A JP 2000159149 A JP2000159149 A JP 2000159149A JP 2001031587 A5 JP2001031587 A5 JP 2001031587A5
Authority
JP
Japan
Prior art keywords
nucleic acid
ehv4
vivo
acid encoding
thymidine kinase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000159149A
Other languages
English (en)
Japanese (ja)
Other versions
JP2001031587A (ja
Filing date
Publication date
Priority claimed from EP99400964A external-priority patent/EP1046400B1/en
Application filed filed Critical
Publication of JP2001031587A publication Critical patent/JP2001031587A/ja
Publication of JP2001031587A5 publication Critical patent/JP2001031587A5/ja
Pending legal-status Critical Current

Links

JP2000159149A 1999-04-20 2000-04-20 ヒト細胞を処理するための方法及び組成物 Pending JP2001031587A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99400964A EP1046400B1 (en) 1999-04-20 1999-04-20 Use of an Equine herpes virus type-4 thymidine kinase and a nucleoside analog selected from ganciclovir and acyclovir for the killing of human proliferative cells
EP99400964.5 1999-04-20

Publications (2)

Publication Number Publication Date
JP2001031587A JP2001031587A (ja) 2001-02-06
JP2001031587A5 true JP2001031587A5 (ko) 2007-05-31

Family

ID=8241950

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000159149A Pending JP2001031587A (ja) 1999-04-20 2000-04-20 ヒト細胞を処理するための方法及び組成物

Country Status (5)

Country Link
EP (1) EP1046400B1 (ko)
JP (1) JP2001031587A (ko)
AT (1) ATE298245T1 (ko)
CA (1) CA2306355A1 (ko)
DE (1) DE69925894T2 (ko)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5757608B2 (ja) * 2009-11-18 2015-07-29 国立大学法人 千葉大学 遺伝子スイッチおよび遺伝子回路の選択方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9014951D0 (en) * 1990-07-06 1990-08-29 Univ Glasgow Equine herpesvirus-4 tk vaccine
FR2716459B1 (fr) * 1994-02-22 1996-05-10 Univ Paris Curie Système hôte-vecteur utilisable en thérapie génique.

Similar Documents

Publication Publication Date Title
Mattson et al. Brain injury and tumor necrosis factors induce calbindin D‐28k in astrocytes: evidence for a cytoprotective response
Chandler et al. Matrix‐enabled gene transfer for cutaneous wound repair
US6811774B2 (en) Defective recombinant adenoviruses expressing cytokines for antitumor treatment
RU2001117230A (ru) Пептиды, ингибирующие трансформирующий фактор роста tgf$$$1
SI1496944T1 (sl) Izboljšani sistemi ekspresije RAAV za genetsko modifikacijo specifičnih kapsidnih proteinov
PT1062321E (pt) Utilizacoes para celulas estaminais mesenquimais humanas nao autologas
JP2003527064A5 (ko)
ATE192500T1 (de) Rekombinante viren vektoren zur expression in muskelzellen
DE69914932D1 (de) Verwendung eines zytokine-produzierenden lactococcus stammes zur behandlung von kolitis
CA2100553A1 (en) Treatment of neoplastic disease with interleukin-10
DE602005024805D1 (de) Adenovirus/alphavirus-hybrid-vektor zur effektiven verabreichung und expression von therapeutischen genen in tumorzellen
JP2002503642A5 (ko)
JP2004501650A5 (ko)
JP2003528138A5 (ko)
JP2001031587A5 (ko)
JPH0971542A (ja) 遺伝子製剤
ES2372728T3 (es) Cicatrización de heridas mediante la administración de il-18 humana.
KR100431779B1 (ko) 유전자제제
KR970706397A (ko) IV a2 유전자가 불활성화된 결손 재조합 아데노바이러스(DEFECTIVE RECOMBINANT ADENOVIRUSES WITH AN INACTIVATED IV a2 GENE)
HK1002284A1 (en) Novel implant and novel vector for the treatment of acquired diseases
BR9812138A (pt) Métodos e composições para terapias empregando genes codificando proteìnas segregadas tal como interferon-beta
KR20010043764A (ko) 안정한 유전자 제제
JP2003189887A5 (ko)
WO2000006735A8 (en) Interferon alpha hybrids
Evans et al. Arthritis